SCHEMBL14598360

SCHEMBL14598360

C=C(C)NCC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19625172 0.84 — —
SCHEMBL3826024 0.77 — —
SCHEMBL18890835 0.75 — —
SCHEMBL8519755 0.74 — —
SCHEMBL868382 0.74 — —
SCHEMBL13814752 0.74 — —
SCHEMBL15384230 0.72 — —
SCHEMBL14367314 0.72 — —
SCHEMBL25882969 0.72 — —
SCHEMBL12012103 0.72 HSD17B10 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170166563-A1 2-AMINO-BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS 5-LIPOXYGENASE AND/OR PROSTAGLANDIN E SYNTHASE INHIBITORS INSTITUT PASTEUR KOREA (KR) 2017-06-15 — — US disclosed
EP-2565268-A1 NOVEL MUC1 ANTIBODY Shionogi&Co., Ltd. (JP) 2013-03-06 — — EP disclosed
US-7163921-B1 Peptide derivatives and medicinal compositions NIPPON SHINYAKU CO., LTD. (JP) 2007-01-16 — — US disclosed
Send feedback